Multifunctionality of PAI-1 in fibrogenesis:: Evidence from obstructive nephropathy in PAI-1-overexpressing mice

被引:117
作者
Matsuo, S
López-Guisa, JM
Cai, XH
Okamura, DM
Alpers, CE
Bumgarner, RE
Peters, MA
Zhang, GQ
Eddy, AA
机构
[1] Univ Washington, Dept Pediat, Seattle, WA 98105 USA
[2] Childrens Hosp & Reg Med Ctr, Seattle, WA 98105 USA
[3] Univ Washington, Dept Pathol, Seattle, WA 98105 USA
[4] Univ Washington, Dept Microbiol, Seattle, WA 98105 USA
关键词
interstitial fibrosis; plasminogen activator inhibitor-1; macrophage; urokinase; unilateral ureteral obstruction;
D O I
10.1111/j.1523-1755.2005.00327.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Plasminogen activator inhibitor-1 (PAI-1) has been implicated in the pathogenesis of chronic kidney disease based on its up-regulated expression and on the beneficial effects of PAI-1 inhibition or depletion in experimental models. PAI-1 is a multifunctional protein and the mechanisms that account for its profibrotic effects have not been fully elucidated. Methods. The present study was designed to investigate PAI-1-dependent fibrogenic pathways by comparing the unilateral ureteral obstruction model (UUO) (days 3, 7, and 14) in PAI-I-overexpressing mice (PAI-1 tg) to wild-type mice, both on a C57BL6 background. Results. Following UUO, total kidney PAI-1 mRNA and/or protein levels were significantly higher in the PAI-1 tg mice (N = 6 to 8/group) and fibrosis severity was significantly worse (days 3, 7, and 14), measured both as Sirius red-positive interstitial area (e.g., 10 +/- 3.2% vs. 4.5 +/- 1.0%) (day 14) and total kidney collagen (e.g., 11.1 +/- 1.7 vs. 6.2 +/- 1.3 mu g/mg) (day 14). By day 14, the expression of two normal tubular proteins, E-cadherin and Ksp-cadherin, were significantly lower in the PAI-1 tg mice (3.2 +/- 0.5% vs. 11.7 +/- 5.9% and 2.6 +/- 1.6) vs. 6.2 +/- 0.8%, respectively), implying more extensive tubular damage. At least four fibrogenic pathways were differentially expressed in the PAI-1 tg mice. First, interstitial macrophage recruitment was more intense (P < 0.05 days 3 and 14). Second, interstitial myofibroblast density was greater (P < 0.05 days 3 and 7) despite similar numbers of proliferating tubulointerstitial cells. Third, transforming growth factor-beta 1 (TGF-beta 1) and collagen I mRNA were significantly higher. Finally, urokinase activity was significantly lower (P < 0.05 days 7 and 14) despite similar mRNA levels. Gene microarray studies documented that that the deletion of this single profibrotic gene had far-reaching consequences on renal cellular responses to chronic injury. Conclusion. These data provide further evidence that PAI-1 is directly involved in interstitial fibrosis and tubular damage via two primary overlapping mechanisms: early effects on interstitial cell recruitment and late effects associated with decreased urokinase activity.
引用
收藏
页码:2221 / 2238
页数:18
相关论文
共 47 条
[31]   Cloning of the 5′ regulatory regions and functional characterization of the core promoters of ovine PLAU (u-PA) and SERPIN1 (PAI-1) [J].
Lampidonis, A. D. ;
Theodorou, G. ;
Pecorini, C. ;
Rebucci, R. ;
Baldi, A. ;
Politis, I. .
GENE, 2011, 489 (01) :11-20
[32]   PAI-1 Exacerbates White Adipose Tissue Dysfunction and Metabolic Dysregulation in High Fat Diet-Induced Obesity [J].
Wang, Lin ;
Chen, Liyuan ;
Liu, Zheran ;
Liu, Yaofang ;
Luo, Mao ;
Chen, Ni ;
Deng, Xin ;
Luo, Yulin ;
He, Jing ;
Zhang, Liping ;
Hill, Michael A. ;
Li, Rong ;
Wu, Jianbo .
FRONTIERS IN PHARMACOLOGY, 2018, 9
[33]   Novel regulatory mechanism and functional implication of plasminogen activator inhibitor-1 (PAI-1) expression in CpG-ODN-stimulated macrophages [J].
Thapa, Bikash ;
Kim, Yeon Hyang ;
Kwon, Hyung-Joo ;
Kim, Doo-Sik .
MOLECULAR IMMUNOLOGY, 2012, 49 (04) :572-581
[34]   Concentrations of plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in induced sputum of asthma patients after allergen challenge [J].
Kowal, Krzysztof ;
Moniuszko, Marcin ;
Zukowski, Sebastian ;
Bodzenta-Lukaszyk, Anna .
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2010, 48 (04) :518-523
[35]   UROKINASE (UPA) AND ITS INHIBITOR PAI-1 ARE STRONG AND INDEPENDENT PROGNOSTIC FACTORS IN NODE-NEGATIVE BREAST-CANCER [J].
JANICKE, F ;
SCHMITT, M ;
PACHE, L ;
ULM, K ;
HARBECK, N ;
HOFLER, H ;
GRAEFF, H .
BREAST CANCER RESEARCH AND TREATMENT, 1993, 24 (03) :195-208
[36]   RETINAL-PIGMENT EPITHELIAL-CELLS SECRETE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR PAI-1 [J].
SIREN, V ;
STEPHENS, RW ;
SALONEN, EM ;
VAHERI, A ;
SUMMANEN, P ;
IMMONEN, I .
OPHTHALMIC RESEARCH, 1992, 24 (04) :203-212
[37]   Mutational analysis of the genes encoding urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in advanced ovarian cancer [J].
Turkmen, B ;
Schmitt, M ;
Schmalfeldt, B ;
Trommler, P ;
Hell, W ;
Creutzburg, S ;
Graeff, H ;
Magdolen, V .
ELECTROPHORESIS, 1997, 18 (05) :686-689
[38]   Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma [J].
Dorn, Julia ;
Harbeck, Nadia ;
Kates, Ronald ;
Magdolen, Viktor ;
Grass, Linda ;
Soosaipillai, Antoninus ;
Schmalfeldt, Barbara ;
Diamandis, Eleftherios P. ;
Schmitt, Manfred .
BIOLOGICAL CHEMISTRY, 2006, 387 (08) :1121-1128
[39]   PAI-1 Leads to G1-Phase Cell-Cycle Progression through Cyclin D3/cdk4/6 Upregulation [J].
Giacoia, Evan Gomes ;
Miyake, Makito ;
Lawton, Adrienne ;
Goodison, Steve ;
Rosser, Charles J. .
MOLECULAR CANCER RESEARCH, 2014, 12 (03) :322-334
[40]   MiR-10a and miR-181c regulate collagen type I generation in hypertrophic scars by targeting PAI-1 and uPA [J].
Li, Chao ;
Zhu, Hua-Yu ;
Bai, Wen-Dong ;
Su, Lin-Lin ;
Liu, Jia-Qi ;
Cai, Wei-Xia ;
Zhao, Bin ;
Gao, Jian-Xin ;
Han, Shi-Chao ;
Li, Jun ;
Hu, Da-Hai .
FEBS LETTERS, 2015, 589 (03) :380-389